Related Experiment Video

Updated: Jun 10, 2026

In Vitro Assay to Study Tumor-macrophage Interaction
08:36

In Vitro Assay to Study Tumor-macrophage Interaction

Published on: August 1, 2019

Chemokine signaling in cancer: Implications on the tumor microenvironment and therapeutic targeting

Stacey L Hembruff1, Nikki Cheng

  • 1Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, University of Kansas Cancer Center; Kansas City, KS 66160.

Cancer Therapy
|July 24, 2010
PubMed

Insights

Chemokines regulate immune cell movement and are crucial for cancer progression. Targeting chemokine signaling pathways offers potential new cancer therapeutics by modulating the tumor microenvironment.

Area of Science:

  • Immunology
  • Oncology
  • Molecular Biology

Background:

  • Chemokines are key regulators of immune cell trafficking in inflammation and pathogen defense.
  • Dysregulated chemokine signaling pathways (CCL2, CCL5, CXCL1, CXCL12) are linked to cancer progression.
  • Emerging evidence highlights chemokines' roles beyond immunity, influencing angiogenesis and epithelial cell dynamics.

Purpose of the Study:

  • To review the multifaceted roles of chemokine signaling in the tumor microenvironment.
  • To explore the therapeutic potential of targeting chemokine pathways in cancer treatment.

Main Methods:

  • Literature review of studies on chemokine signaling in cancer.
  • Analysis of the impact of chemokines on immune responses and tumor progression.
  • Evaluation of therapeutic strategies targeting chemokine pathways.

Main Results:

  • Chemokine signaling pathways are implicated in various aspects of cancer progression.
  • Chemokines influence angiogenesis, cell growth, and survival within the tumor microenvironment.
  • Targeting chemokines presents a promising avenue for novel cancer therapies.

Conclusions:

  • Chemokine signaling plays a complex and diverse role in cancer progression.
  • Modulating chemokine activity in the tumor microenvironment is a viable therapeutic strategy.
  • Further research into chemokine-based cancer therapeutics is warranted.

More Related Videos

A Proximal Culture Method to Study Paracrine Signaling Between Cells08:17

A Proximal Culture Method to Study Paracrine Signaling Between Cells

Published on: August 28, 2018

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports07:44

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports

Published on: November 28, 2019

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...